Antao Chang
China Medical University(TW)Nankai University(CN)Tianjin Medical University Cancer Institute and Hospital(CN)Translational Research in Oncology(FR)
Publications by Year
Research Areas
Pancreatic and Hepatic Oncology Research, Cancer Cells and Metastasis, Cancer, Hypoxia, and Metabolism, RNA modifications and cancer, PARP inhibition in cancer therapy
Most-Cited Works
- → Zeb1-induced metabolic reprogramming of glycolysis is essential for macrophage polarization in breast cancer(2022)152 cited
- → Tumour-derived Interleukin 35 promotes pancreatic ductal adenocarcinoma cell extravasation and metastasis by inducing ICAM1 expression(2017)137 cited
- → Interleukin 35 Expression Correlates With Microvessel Density in Pancreatic Ductal Adenocarcinoma, Recruits Monocytes, and Promotes Growth and Angiogenesis of Xenograft Tumors in Mice(2017)112 cited
- → ATF4 is directly recruited by TLR4 signaling and positively regulates TLR4-trigged cytokine production in human monocytes(2012)95 cited
- → Irbesartan overcomes gemcitabine resistance in pancreatic cancer by suppressing stemness and iron metabolism via inhibition of the Hippo/YAP1/c-Jun axis(2023)75 cited
- → Liposomal Nanoparticles Carrying anti-IL6R Antibody to the Tumour Microenvironment Inhibit Metastasis in Two Molecular Subtypes of Breast Cancer Mouse Models